Navigation Links
Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
Date:11/24/2008

Company's R&D Update Today Unveils Rich Development Pipeline of Compounds Meeting Important Medical Needs

KENILWORTH, N.J., Nov. 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today revealed top-line results of a long-term Phase III clinical study of its psychopharmacologic agent SAPHRIS(TM) (asenapine) demonstrating efficacy and safety in preventing relapse of schizophrenia. In this trial, asenapine was statistically significantly more effective than placebo in preventing relapse, as measured by the primary endpoint of the trial estimated through Kaplan-Meier curves. At the 26 week endpoint, 47 percent of the placebo-treated patients relapsed, compared with only 12 percent of the asenapine-treated patients (p<0.0001). Asenapine was generally well tolerated, with somnolence and insomnia being the most frequently reported adverse events in the initial open-label treatment phase (occurring in more than 10 percent of patients).

The top-line data were presented today at the company's 2008 R&D Update meeting being hosted for analysts and portfolio managers at company headquarters. The company plans to submit results of the trial for presentation at a future medical meeting.

"Schizophrenia is a serious disease affecting millions of people worldwide, and there is a need for effective new medications with acceptable safety and tolerability profiles," said Thomas P. Koestler, Ph.D., executive vice president and president, Schering-Plough Research Institute. "Asenapine is an important late-stage compound in the Schering-Plough development pipeline, and we are encouraged by the top-line data we are sharing today. We believe that asenapine may have the potential to help relieve the burden of schizophrenia."

Asenapine, administered as a fast-dissolving subl
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
2. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
3. Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
4. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
5. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
6. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
7. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
10. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
11. Schering-Plough Reports Top-Line Results of the IDEAL Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)...  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ... acute care and gastroenterology, today announced fourth quarter ... grew 15% in 2014 to $37 million, resulting ... per diluted share. At the end of 2014, ... including $55 million in cash and investments, with ...
(Date:3/3/2015)... , March 3, 2015 /CNW/ - The ... seized a health product being injected at Art Nails Ltd., located ... appeared to be unauthorized as it contained no labelling. All products ... authorized by Health Canada and must have approved labelling. ... had been administered to consumers. Potential risks associated with injecting an ...
(Date:3/3/2015)... 2015  American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ... actively engaged in the design, development and production ... leading medical device companies has announced the acquisition ... custom medical cable manufacturer based in North Carolina.  ... under the name MTI Medical Cables.  ...
Breaking Medicine Technology:Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 2Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 3Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 4Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 5Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 6Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 7Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 8Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 9Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 11Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 12Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 13Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 14Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 15Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 16Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 17Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 18Advisory - Health product seized from Art Nails in Vancouver 2American Biosurgical Acquires MTI Corporation 2
... Inc. (OTC Bulletin Board: ECTE ), ... as a non-invasive, wireless, transdermal continuous glucose monitoring ... drug delivery, today announced that Patrick Mooney, M.D., ... at the prestigious Accredited Members, Inc. (AMI) Fall ...
... INDIANAPOLIS, Sept. 16 Roche Diagnostics (SIX: RO, ROG; ... complete battery of STAT immunoassays for cardiac biomarker testing ... integrated system designed for diagnostic labs with medium testing ... than any other cardiac immunoassay tests currently available on ...
Cached Medicine Technology:Echo Therapeutics to Present at Prestigious Accredited Members, Inc. Fall 2010 Small Cap/Micro Cap Investment Conference 2Echo Therapeutics to Present at Prestigious Accredited Members, Inc. Fall 2010 Small Cap/Micro Cap Investment Conference 3Roche Diagnostics Introduces Full Line of 9-Minute STAT Assays for Cardiac Biomarker Testing on cobas 6000 Analyzer Series 2Roche Diagnostics Introduces Full Line of 9-Minute STAT Assays for Cardiac Biomarker Testing on cobas 6000 Analyzer Series 3
(Date:3/4/2015)... From the halls of the ... 2015 , AvePoint, the established leader in ... the AvePoint Risk Intelligence System (ARIS) to ... across the enterprise. , Leveraging the templates and question ... (APIA) system – used by more than 2,000 ...
(Date:3/4/2015)... Rocket Builders’ “Ready to Rocket” ranking is a ... best prospect for growth according to driving technology sector ... to Rocket companies, we are looking for those companies ... Prizm Media Inc. is an excellent example of the ... time,” said Reg Nordman, Managing Partner, Rocket Builders. ...
(Date:3/3/2015)... As payers pledge to move the bulk of ... few years, they are testing various initiatives to get ... spending they control — involved. The March issue of ... tracks some of the strategies proposed by industry experts ... (ACO)-type model. , One way to get specialists on ...
(Date:3/3/2015)... On February 21st, the rooftop of the ... a day-long event that features a gathering of providers ... Organized by Debbie Durkin and Durkin Entertainment, Los Angeles’ ... EcoLuxe Lounge saw many notable attendees. Among them was ... The Flash, Star Trek: Deep Space Nine and many, ...
(Date:3/3/2015)... Man, Woman & Student of the ... cures and ensure access to treatments for blood cancer ... and their families. Through this annual national ten-week campaign, ... for a world without blood cancers. The national titles ... country, to be announced this summer. To date, these ...
Breaking Medicine News(10 mins):Health News:AvePoint Unveils New Solution to Address the Complete Risk Lifecycle at IAPP Global Privacy Summit 2015 2Health News:AvePoint Unveils New Solution to Address the Complete Risk Lifecycle at IAPP Global Privacy Summit 2015 3Health News:AvePoint Unveils New Solution to Address the Complete Risk Lifecycle at IAPP Global Privacy Summit 2015 4Health News:Healthcare Lead Generation Leader Prizm Media Inc. is “Ready to Rocket” 2Health News:Healthcare Lead Generation Leader Prizm Media Inc. is “Ready to Rocket” 3Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 2Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 3Health News:Hollywood Star Chase Masterson and Choices Recovery Discuss Substance Abuse and Treatment at 2015 Oscars 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, Feb. ... salmonella outbreak that sickened about 1,500 people and claimed two ... essence in identifying sources of food contamination and preventing further ... and, as an editorial accompanying the paper in the Feb. ...
... to enhance athletic performance have found that bovine colostrum ... ,leaky gut syndrome., Their findings, published in the ... and Liver Physiology , could have positive implications not ... A research group led by Ray Playford, Professor ...
... February 24, 2011 T-cell receptor diversity in blood samples ... time in a study published online today in Genome ... better understanding of infectious disease, cancer, and immune system disorders. ... cell that identifies and attacks cells that may be infected ...
... 23 (HealthDay News) -- How quickly and smoothly people move ... do with the relationships each partner had in earliest childhood ... The finding stems from the the University of Minnesota,s ongoing ... mid-1970s, before the study participants were even born. Doctoral ...
... images from a laser-based tool developed at Duke University could ... cancer, while potentially saving thousands of lives and millions of ... probes skin cells using two lasers to pump small amounts ... a suspicious mole. Scientists analyze the way the energy redistributes ...
... (HealthDay News) -- Smoking increases the production of mucus ... U.S. researchers conducted tests on human airway tissue and ... a protein that causes the natural death of mucus-producing ... study appears online ahead of print in the ...
Cached Medicine News:Health News:Fast Response Crucial in Outbreaks of Food-Borne Illness: Study 2Health News:Fast Response Crucial in Outbreaks of Food-Borne Illness: Study 3Health News:Is dairy colostrum the key to Olympic success? 2Health News:Entire T-cell receptor repertoire sequenced revealing extensive and unshared diversity 2Health News:Early Childhood Might Affect Love Life in Adult 2Health News:Lasers ID deadly skin cancer better than doctors 2Health News:Lasers ID deadly skin cancer better than doctors 3Health News:Cigarette Smoke Fuels Mucus Production in People With Bronchitis 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: